Our industry-leading team of pathologists, microbiologists, and immunologists has demonstrated experience working with multiple classes of pathogens, with deep expertise in antimicrobials and clinical microbiology.
This is critically important since 1 of 4 classes of pathogens causes infectious diseases: bacteria, viruses, fungi, or parasites. These pathogens cause diseases that are often intractable to treatment and can spread rapidly across the globe as we have seen with the SARS-CoV-2 virus; causing an enormous burden on the worldwide healthcare system. The scarcity of effective treatments for infectious diseases and the threat of another pandemic has created urgency to discover and develop novel therapies against these dangerous pathogens, as well as repositioning and repurposing current drugs.
At Eurofins Discovery, we have developed the expertise to meet a variety of study endpoints to generate the high-quality, reproducible data your projects require including minimal data scatter and dose-response to standard antimicrobial agents.
Let our team of experts help you develop efficient screening cascades to enable swift decision-making, allowing you to fast track your anti-infective program. From high-throughput screening to Translational Biology profiling of lead candidates in human cell-based disease models of infectious disease, we strive to be a one-stop shop for discovery in this important therapeutic area.
